-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0283_03-10-2008.pdf
January 01, 2008 - interested in the
evidence base surrounding laparoscopic adjustable gastric banding (LAGB) for the
treatment … Many recent studies on the effectiveness of bariatric
surgery for the treatment of diabetes have shown … bariatric surgery to be more effective in treating type
2 diabetes than conventional therapy. … bariatric surgery,
such as a less invasive laparoscopic gastric banding, should be the first-line treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
December 01, 2013 - purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Experts commenting on this intervention agreed that the need for disease-modifying treatments
for AD … Brain insulin resistance and
deficiency as therapeutic targets in Alzheimer's
disease. … Insulin: compare common
options for insulin therapy. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-intro.ppt
June 01, 2012 - as well as scored questionnaires intended for screening or to assess likely prognosis or response to therapy … Conversely, most treatments lead directly to intended results or adverse effects. … Reprinted with corrections and an updated topical bibliography in 1988 (Los Altos, CA: Peninsula Publishing … It has proven useful for evaluating therapies and can also be applied to the evaluation of medical tests … Reprinted in 1988 with corrections and an updated topical bibliography (Los Altos, CA: Peninsula Publishing
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-intro.ppt
June 01, 2012 - as well as scored questionnaires intended for screening or to assess likely prognosis or response to therapy … Conversely, most treatments lead directly to intended results or adverse effects. … Reprinted with corrections and an updated topical bibliography in 1988 (Los Altos, CA: Peninsula Publishing … It has proven useful for evaluating therapies and can also be applied to the evaluation of medical tests … Reprinted in 1988 with corrections and an updated topical bibliography (Los Altos, CA: Peninsula Publishing
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - Beliefs about the advantages or disadvantages of various alternative treatments are an important target … , another active therapy, or no control therapy
O — Pulmonary variables, anthropometrics, bone variables … Control therapies we would accept were placebo, no therapy, another active therapy, or no control therapy … duration, baseline nutritional status, and concurrent medical therapies? … duration, baseline nutritional status, and concurrent medical therapies?
-
effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_potential_high_impact_2012-12-10.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … Early-intervention treatment includes behavior and communication therapies (including
applied behavior … archived from the horizon scanning system
after expert comment processes include hyperbaric oxygen therapy … STX209 (arbaclofen, Seaside Therapeutics, Cambridge,
MA) is a gamma aminobutyric acid (GABA)-B agonist
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0316_03-12-2009.pdf
January 01, 2009 - It can also be used to adjust anti-hypertensive drug therapy and reduce clinic visits
with patients. … What is the effect of treatment guided by SMBP in comparison to treatment guided by
clinic BP, in terms … Use of anti-hypertensive drug therapy
iv. BP control
3. … What is the effect of treatment guided by ABP in comparison to treatment guided by clinic BP,
in terms … Use of anti-hypertensive drug therapy
iv. BP control
4.
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1406.pdf
February 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … predominantly symptom-
management options; however, emerging research aims to identify disease-modifying therapies … AD pathogenesis, leading researchers to investigate intranasally delivered insulin as a
potential therapy … Intranasal delivery
bypasses the blood-brain barrier to target
therapeutic agents to the central … Intranasal
insulin therapy for Alzheimer disease and
amnestic mild cognitive impairment: a pilot
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … Helminthic therapy (pig whipworm) for treatment-resistant ulcerative colitis No high-impact potential … POEM was ineffective in
three patients because of severe submucosal fibrosis attributed to previous therapies … Finally, one
expert representing a clinical perspective stated that no therapies are available to promote
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - therapeutic effects and better glycemic control. … therapeutic effects and better glycemic control. … Both anti-angiogenic and corticosteroid treatments require ongoing treatment involving multiple
intravitreal … Topical collection on lipid and
metabolic effects of gastrointestinal surgery. … Investigational
therapeutic options in the management of DME:
investigational pharmacologic treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
June 01, 2014 - , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … cognitive behavior therapies. … efficacy for suicidal ideation
and as an adjunct treatment to behavior and brain-stimulation therapies … added to existing therapies. … Therapeutic options in
treatment-resistant depression. Ann Med. 2011
Nov;43(7):512-30.
-
hcup-us.ahrq.gov/reports/statbriefs/sb142.jsp
September 01, 2012 - Data
Methods Series
ICD-10-CM/PCS Resources
Database Reports
Additional Topics and Archives
Topical … The smallest differences in readmission rates by community income level were observed for CABG and treatment … With the exception of CABG and treatment for hip or femur fracture, readmission rates for individuals … were defined using procedure classes, which categorize each ICD-9-
CM procedure code as either major therapeutic … , major diagnostic, minor therapeutic or minor diagnostic.
-
datatools.ahrq.gov/nhqdr/
January 01, 2023 - Effective care means delivering optimal treatments for acute illness to help reduce the consequences … The effective treatment measures include measures for preventive care, treatment of acute illness, and … Effective care means delivering optimal treatments for acute illness to help reduce the consequences … The effective treatment measures include measures for preventive care, treatment of acute illness, and … Effective care means delivering optimal treatments for acute illness to help reduce the consequences
-
effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery
innovations that address … *Platelet-rich plasma therapy for treatment of osteoarthritis Moderately high
6. … provided by PRP for knee OA was 9 months.
27
Autologous PRP is not currently considered a drug or a therapeutic … for Treatment of Osteoarthritis
Platelet-Rich Plasma Therapy for Treatment of Osteoarthritis
Rheumatoid
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
January 01, 2020 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … for pain management or help with treating opioid dependence, interventions include
detoxification treatments … , opioid replacement therapy (i.e., methadone or buprenorphine
maintenance therapy), or other inpatient
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … All experts generally indicated that these antiobesity therapies have high potential to meet a
significant … the company in March 2011.
57
As of July 25, 2011, the system had
been approved by the Australian Therapeutic … Goods Administration for inclusion in its therapeutic
goods registry for treatment of T2DM and obesity … Orexigen Therapeutics provides a regulatory
update on Contrave NDA. [internet].
-
psnet.ahrq.gov/sites/default/files/2023-01/spotlight_overdose_of_gabapentin_and_oxycodone_in_a_patient_with_end-stage_renal_disease.pdf
January 01, 2023 - • Oxycodone is considered a second-line therapy compared with other
opioids and may be used with … including baclofen, tizanidine, cyclobenzaprine, and
methocarbamol, are commonly used as adjunctive treatments …
• Topical NSAIDs such as diclofenac gel have reduced systemic
absorption compared to their oral … • As such, topical agents should be considered in patients with CKD who
have musculoskeletal and arthritic … patient-
specific information, usually at the point of care, to help inform decisions
about a patient's treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … New drug treatment options are needed for obese patients seeking
medical therapy for weight loss. … with antiobesity pharmacotherapies and potential
third-party payers’ unwillingness to cover these therapies … Goods Administration for inclusion in its therapeutic
goods registry for treating T2DM and obesity
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/qWZxPBqpffTYVNvGYPkohz
May 01, 2021 - Treatment or Interventions
Treatment for anxiety disorders can include psychotherapy, phar-
macotherapy … limited evidence was
available on accuracy of screening questionnaires and effective-
ness of anxiety treatments … and pharmaco-
therapy and combinations thereof. … One study evaluated homicidal ide-
ation but showed no pattern with cognitive behavioral therapy. … US Department of Commerce. 2020 National
Survey of Children’s Health: Topical Frequencies.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-207-ptsd-disposition-comments.pdf
May 17, 2018 - SR in 2013 of
psychological therapies for chronic PTSD) have classified
CBT treatments (that are not … other specific therapies,
such as cognitive therapy, cognitive processing therapy,
etc.) as trauma-focused … • Cognitive processing therapy
• Cognitive restructuring
• Exposure-based therapies
• Coping skills … therapy
• Various “mixed” therapies
Eye movement desensitization and reprocessing
Other psychological … or behavioral therapies
• Psychodynamic therapy
• Interpersonal therapy
• Group therapy
• Hypnosis